Albuminuria in children

Current Opinion in Nephrology and Hypertension

Volumn 18, Issue 3, 2009, Pages 246-251

  Rademacher, Erin R ^a,c   Sinaiko, Alan R ^b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^c UNIVERSITY OF ROCHESTER   (United States)

Author keywords

Albuminuria; Children; Epidemiology

Indexed keywords

ALBUMIN; GLUCOSE; HEMOGLOBIN A1C; INSULIN; LIPID;

ALBUMINURIA; BLOOD PRESSURE; BODY MASS; CARDIOVASCULAR RISK; GENETIC POLYMORPHISM; HUMAN; HYPERTENSION; INSULIN DEPENDENT DIABETES MELLITUS; INSULIN RESISTANCE; MICROALBUMINURIA; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; PRIORITY JOURNAL; PROGNOSIS; PROTEIN SECRETION; REVIEW; ADOLESCENT; AGING; ANIMAL; CARDIOVASCULAR DISEASE; CHILD; DIABETES MELLITUS; KIDNEY DISEASE; METABOLISM; PHYSIOLOGY; REFERENCE VALUE; RISK FACTOR; URINE;

ADOLESCENT; AGING; ALBUMINURIA; ANIMALS; CARDIOVASCULAR DISEASES; CHILD; DIABETES MELLITUS; HUMANS; KIDNEY DISEASES; OBESITY; REFERENCE VALUES; RISK FACTORS;

EID: 67049133241     PISSN: 10624821     EISSN: None     Source Type: Journal    
DOI: 10.1097/MNH.0b013e3283294b98     Document Type: Review

References (54)

1. Parving H, Oxenball B, Svendsen P, et al. Early detection of patients at risk of developing diabetic nephropathy. A longitudinal study of urinary albumin excretion. Acta Endocrinol 1982; 100:550-555.
2. Viberti G, Jarrett R, Mahmud U, et al. Microalbuminuria as a predictor of clinical nephropathy in inulin-dependent diabetes mellitus. Lancet 1982; 1:1430-1432.
3. Mogensen C. Microalbuminuria predicts clinical proteinuria and early mortality in maturity-onset diabetes. N Engl J Med 1984; 310:356-360.
4. Gerstein H, Mann J, Yi Q, et al. Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals. JAMA 2001; 286:421-426.
5. Hillege HL, Janssen MT, BakAAA, et al. Microalbuminuria is common, also in a nondiabetic, nonhypertensive population, and an independent indicator of cardiovascular risk factors and cardiovascular morbidity. J Intern Med 2001; 249:519-526.
6. Yuyun MF, Khaw K-T, Luben R, et al. A prospective study of microalbuminuria and incident coronary heart disease and its prognostic significance in a British population. Am J Epidemiol 2004; 159:284-293.
7. Bigazzi R, Bianchi S, Baldari D, et al. Microalbuminuria predicts cardiovascular events and renal insufficiency in patients with essential hypertension. J Hypertension 1998; 16:1325-1333.
8. Arnlov J, Evans J, Meigs J, et al. Low-grade albuminuria and incidence of cardiovascular disease events in nonhypertensive and nondiabetic individuals: the Framingham Study. Circulation 2005; 112:969-975.
9. Borch-Johnsen K, Feldt-Rasmussen B, Strandgaard S, et al. Urinary albumin excretion an independent predictor of ischemic heart disease. Arterioscler Thromb Vasc Biol 1999; 19:1992-1997.
10. Stehouwer CDA, Smulders YM. Microalbuminuria and risk for cardiovascular disease: analysis of potential mechanisms. J Am Soc Nephrol 2006; 17:2106-2111.
11. Satchell SC, Tooke JE. What is the mechanism for microalbuminuria in diabetes: a role for the glomerular endothelium. Diabetologia 2008; 51:714-725.
12. Lande M, Carson N, Roy J, et al. Effects of childhood primary hypertension on carotid intima media thickness: a matched controlled study. Circulation 2006; 48:40-44.
13. Aggoun Y, Farpour-Lambert N, Marchand L, et al. Impaired endothelial and smooth muscle functions and arterial stiffness appear before puberty in obese children and are associated with elevated ambulatory blood pressure. Eur Heart J 2008; 29:792-799.
14. Bangstad H-J, Dahl-Jorgensen K, Kjaersgaard P, et al. Urinary albumin excretion rate and puberty in nondiabetic children and adolescents. Acta Paediatr 1993; 82:857-862.
15. Couper J, Staples A, Cocciolone R, et al. Relationship of smoking and albuminuria in children with insulin-dependent diabetes. Diabet Med 1994; 11:666-669.
16. Davies AR, Postlethwaite DB, Price JL, et al. Urinary albumin excretion in school children. Arch Dis Child 1984; 59:625-630.
17. Garg S, Chase H, Harris S, et al. Glycemic control and longitudinal testing for exercise microalbuminuria in subjects with Type I diabetes. J Diabet Complications 1990; 4:154-158.
18. Lorini R, d'Annunzio G, Vitali L, et al. Normal values of overnight albumin excretion rates in a sample of healthy Italian children and adolescents. J Endocrinol Metab 1998; 11:639-643.
19. Sanchez-Bayle M, Rodriguez-Cimadevilla C, Asensio C, et al. Urinary albumin excretion in Spanish children. Pediatr Nephrol 1995; 9:428-430.
20. Skinner A, Addison G, Price D. Changes in the urinary excretion of creatinine, albumin and N-acetyl-B-D-glucosaminidase with increasing age and maturity in healthy schoolchildren. Eur J Pediatr 1996; 155:596-602.
21. Rademacher E, Mauer M, Jacobs DR Jr, et al. Albumin excretion rate in normal adolescents: relation to insulin resistance and cardiovascular risk factors and comparisons to type 1 diabetes mellitus patients. Clin J Am Soc Nephrol 2008; 3:998-1005. This is the first study to investigate albuminuria's relationship to cardiovascular risk factors in adolescents. It also showed that adolescents with type 1 diabetes have albumin excretion rates higher than healthy adolescents, despite having rates well below the range of microalbuminuria.
22. Hanevold CD, Pollock JS, Harshfield GA. Racial differences in microalbumin excretion in healthy adolescents. Hypertension 2008; 51:334-338. This study describes higher albumin excretion in African-American adolescents and that systolic blood pressure predicts albumin excretion in African-American males but not in females or in Caucasians.
23. Trachtenberg F, Barregard L The effect of age, sex, and race on urinary markers of kidney damage in children. Am J Kidney Dis 2007; 50:938-945.
24. Csernus K, Lanyi E, Erhardt E, et al. Effect of childhood obesity and obesity-related cardiovascular risk factors on glomerular and tubular protein excretion. Eur J Pediatr 2005; 164:44-49.
25. Burgert T, Dziura J, Yeckel C, et al. Microalbuminuria in pediatric obesity: prevalence and relation to other cardiovascular risk factors. Int J Obes (Lond) 2006; 30:273-280.
26. Invitti C, Maffeis C, Gilardini L, et al. Metabolic syndrome in obese Caucasian children: prevalence using WHO-derived criteria and association with nontraditional cardiovascular risk factors. Int J Obes (Lond) 2006; 30:627-633.
27. Nguyen S, McCulloch C, Brakeman P, et al. Being overweight modifies the association between cardiovascular risk factors and microalbuminuria in adolescents. Pediatrics 2008; 121:37-45. This study used NHANES data to show that the relation of albuminuria to cardiovascular risk differed depending on the weight status of the subjects. This finding supports the idea that albuminuria functions as an integrated marker of risk and may be the final endpoint of multiple adverse risk factors.
28. Dunger DB, Schwarze CP, Cooper JD, et al. Can we identify adolescents at high risk for nephropathy before the development of microalbuminuria? Diabetic Med 2007; 24:131-136.
29. Steinke J, Sinaiko A, Kramer M, et al. The early natural history of nephropathy in Type 1 diabetes: III. Predictors of 5-year urinary albumin excretion patterns in initially normoalbuminuric patients. Diabetes 2005; 54:2164-2171.
30. Amin R, Widmer B, Prevost AT, et al. Risk of microalbuminuria and progression to macroalbuminuria in a cohort with childhood onset type 1 diabetes: prospective observational study. BMJ 2008; 336:697-701. This study confirms earlier reports that microalbuminuria may regress; however, both persistent and intermittent microalbuminuria predict progression to macroalbuminuria but transient microalbuminuria does not. Careful long-term monitoring is important to distinguish the microalbuminuria phenotype.
31. Dronavalli S, Duka I, Bakris GL The pathogenesis of diabetic nephropathy. Nat Clin Pract 2008; 4:444-452.
32. Ahmed N, Thornalley PJ. Advanced glycation endproducts: what is their relevance to diabetic complications? Diabetes Obes Metab 2007; 9:233-245.
33. Craig ME, Duffin AC, Gallego PH, et al. Plantar fascia thickness, a measure of tissue glycation, predicts the development of complications in adolescents with type 1 diabetes. Diabetes Care 2008; 31:1201-1206.
34. Harjutsalo V, Katoh S, Sarti C, et al. Population-based assessment of familial clustering of diabetic nephropathy in Type 1 diabetes. Diabetes 2004; 53: 2449-2454.
35. Fioretto P, Steffes MW, Barbosa J, et al. Is diabetic nephropathy inherited? Studies of glomerular structure in Type 1 diabetic sibling pairs. Diabetes 1999; 48:865-869.
36. Wiltshire EJ, Gent R, Hirte C, et al. Endothelial dysfunction relates to folate status in children and adolescents with type 1 diabetes. Diabetes 2002; 51:2282-2286.
37. Stehouwer CDA, Fischer A, van Kuuk AWR, et al. Endothelial dysfunction precedes the development of microalbuminuria in IDDM. Diabetes 1995; 44:561-564.
38. Verrotti A, Greco R, Basciani F, et al. von Willebrand Factor and its propeptide in children with diabetes. Relation between endothelial dysfunction and microalbuminuria. Pediatr Res 2003; 53:382-386.
39. Wiltshire EJ, Mohsin F, Chan A, et al. Methylenetetrahydrofolate reductase and methionine synthase reductase gene polymorphisms and protection from microvascular complications in adolescents with type 1 diabetes. Pediatr Diabetes 2008; 9 (Part II):348-353.
40. Gallego PH, Shepherd N, Bulsara MK, et al. Angiotensinogen gene T235 variant: a marker for the development of persistent microalbuminuria in children and adolescents with type 1 diabetes mellitus. J Diabetes Complications 2008; 22:191-198.
41. Winkelmann RB, Russ PA, Nauck M, et al. Angiotensinogen M235T polymorphism is associated with plasma angiotensinogen and cardiovascular disease. Am Heart J 1999; 137:698-705.
42. Jeunemaitre X, Soubrier F, Kotelevtsev YV, et al. Molecular basis of human hypertension: role of angiotensinogen. Cell 1992; 71:169-180.
43. Adler AI, Stevens RJ, Manley SE, et al. Development and progression of nephropathy in type 2 diabetes: The United Kingdom Prospective Diabetes Study (UKPDS 64). Kidney Int 2003; 63:225-232.
44. Maahs DM, Snively BM, Bell RA, et al. Higher prevalence of elevated albumin excretion in youth with type 2 than type 1 diabetes: The SEARCH for Diabetes in Youth Study. Diabetes Care 2007; 30:2593-2598. Prevalence of microalbuminuria was higher in adolescents with type 2 diabetes than in those with type 1 diabetes. Microalbuminuria was more common in ethnic minorities with type 2 diabetes and its presence was not fully explained by traditional cardiovascular risk factors or insulin resistance.
45. Ettinger LM, Freeman K, DiMartino-Nardi JR, et al. Microalbuminuria and abnormal ambulatory blood pressure in adolescents with type 2 diabetes mellitus. J Pediatr 2005; 147:67-73.
46. Keijzer-Veen MG, Schrevel M, Finken MJJ, et al. Microalbuminuria and lower glomerular filtration rate at young adult age in subjects born very premature and after intrauterine growth retardation. J Am Soc Nephrol 2005; 16:2762-2768.
47. Maahs DM, Snively BM, Beyer J, et al. Weight and elevated albumin to creatinine ratio in youth with diabetes: the SEARCH for Diabetes in Youth study. Pediatr Nephrol 2008; 23:2255-2260.
48. Schreuder MF, Langemeijer ME, Bökenkamp A, et al. Hypertension and microalbuminuria in children with congenital solitary kidneys. J Paediatr Child Health 2008; 44:363-368.
49. Lou-Meda R, Oakes R, Gilstrap J, et al. Prognostic significance of microalbuminuria in postdiarrheal hemolytic uremic syndrome. Pediatr Nephrol 2007; 22:117-120.
50. Garg AX, Salvadori M, Okell JM, et al. Albuminuria and estimated GFR 5 years after Escherichia coli O157 hemolytic uremic syndrome: an update. Am J Kidney Dis 2008; 51:435-444.
51. Pedrinelli R, Dell'omo G, di Bello V, et al. Microalbuminuria, an integrated marker of cardiovascular risk in essential hypertension. J Hum Hypertens 2002; 16:79-89.
52. Assadi F. Effect of microalbuminuria lowering on regression of left ventricular hypertrophy in children and adolescents with essential hypertension. Pediatr Cardiol 2007; 28:27-33.
53. Assadi F. Relation of left ventricular hypertrophy to microalbuminuria and C-reactive protein in children and adolescents with essential hypertension. Pediatr Cardiol 2008; 29:580-584.
54. Belsha CW, Well TG, McNiece KL, et al. Influence of diurnal blood pressure variations on target organ abnormalities in adolescents with mild essential hypertension. Am J Hypertens 1998; 11:410-417.